Wednesday, August 7, 2013

Venus Remedies Limited - RESULTS FOR - Q1 FY 2013-14 - Q/E JUNE 2013 -SALES UP 13%;NPT UP 9% YoY - FUTURE APPEARS BRIGHT




Venus Remedies Limited

RESULTS FOR Q1 FY 2013-14
Q/E JUNE 2013


Venus Remedies has declared reasonably good results for the first quarter ending June, 2013.

Net Sales for Q1 FY 14 stands at Rs.126.65 Cr; up by 1.29% from Q4 FY 13 (Rs.125.03 Cr); and up by 13.04%  from Q1 FY 13 (Rs.112.03 Cr).

Total Expenditure  for Q1 FY 14 stands at Rs.105.14 Cr; up by 1.83% from Q4 FY 13 (Rs.103.25 Cr); and up by    16.02%  from Q1 FY 13 (Rs.90.62Cr).

Profit before Interest, Dep. & Taxes   for Q1 FY 14 stands at Rs.21.51 Cr;  down by     -1.25% from Q4 FY 13 (Rs.21.78 Cr); and up by 0.45%  from Q1 FY 13 (Rs.21.41Cr).

Profit  before tax   for Q1 FY 14 stands at Rs.16.21 Cr; up by 4.19% from Q4 FY 14 (Rs.15.56 Cr); and up by 12.08% from Q1 FY 13 (Rs.14.46 Cr).

Tax Expenses for Q1 FY 14 stands at Rs.0.9 cr; down by -75.11% from Q4 FY 13 (Rs.3.6 Cr); and up by 115.11% from Q1 FY 13 (Rs.0.417 Cr)

Net Profit       for Q1 FY 14 stands at Rs.15.31Cr; up by 28.1% from Q4 FY 13 (Rs.11.95 Cr); and up by  9.02%  from Q1 FY 13 (Rs.14.05 Cr).

Face Value  of the share is Rs.10

Paid-up Equity stands at Rs.11.442 cr ;up by 8.54% from Q4 FY13 (Rs. 10.542Cr) and up by 17.45% from Q1 FY 13 (Rs.9.742 Cr).

Basic EPS  for Q1 FY 14 stands at Rs.13.38; against Rs.        11.34 in Q4 FY 13; and Rs.14.42 in Q1 FY 13

Public Shareholding in the company stands at 56.26%; down from 65.58% in Q1 FY 13.

CURRENT Market price : Rs.173.00  As on 06-AUG-2013 16:00:01

The Annualized EPS would be Rs.13.38 x 4 =  53.52

The PE Ratio would be 3.23; The performance of the company has been gradually moving up. The current Profits and EPS are reasonably good. The company is bagging new patents regularly. However, it must convert them into sales and profits in a Big way. It has not yet tapped the large regulated markets.  However, given the impressive array of Patents wide across the Globe, the company’s performance can be expected to move up only in future and give good returns.

52 week high/low price : Rs.358.45/140.00

Dividend History :

        20-Sep-2012   :     DIV RS. 3/- PER SHARE  
        22-Sep-2011   :     DIV RS.3/- PER SHARE   
        23-Sep-2010   :     DIV RS.3/- PER SHARE   
        17-Sep-2009   :     DIV-RS.3/- PER SHARE   
        12-Sep-2008   :     DIV - 40%      

RESULTS TABLE :

Venus Remedies
30-Jun-13
%Dif QoQ
31-Mar-13
31-Dec-12
30-Sep-12
%Dif Yoy
30-Jun-12
Net Sales
12664.5
1.29
12502.8
11162.4
11041.1
13.04
11203.4
Total Expenditure
10513.6
1.83
10324.7
9074.3
9000.1
16.02
9062.1
Profit before Interest, Dep. & Taxes
2150.9
-1.25
2178.1
2088.1
2041
0.45
2141.3
Net Profit
1531.2
28.1
1195.3
1605.5
1509.2
9.02
1404.5
Total Income
12720.8
1.51
12531.7
11263.6
11081.3
13
11257.2
Changes in inventories
-28
-91.2
-318.3
5.5
-319
-90.59
-297.5
Cost of materials
7525
-4.22
7856.8
6353.5
6521.8
15.35
6523.7
Employee benefits
591.7
0.51
588.7
583.5
580.6
3.63
571
Depreciation
953.5
19.08
800.7
800.9
797.7
22.73
776.9
Other expenses
1471.4
5.34
1396.8
1330.9
1419
-1.12
1488
Total expenses
10513.6
1.83
10324.7
9074.3
9000.1
16.02
9062.1
Profit  before tax
1620.9
4.19
1555.7
1694.4
1570.9
12.08
1446.2
Tax Expenses
89.7
-75.11
360.4
88.9
-
115.11
41.7
Net Profit
1531.2
28.1
1195.3
1605.5
1509.2
9.02
1404.5
Face Value
10

0
0
0

0
Paid-up Equity
1144.2
8.54
1054.2
974.2
974.2
17.45
974.2
Basic EPS
13.38
17.99
11.34
16.48
15.49
-7.21
14.42
Public Shareholding (%)
56.26
-7.86
61.06
66.08
66.08
-14.21
65.58


 *  *  *   E  N  D  *  *  *

No comments:

Post a Comment